pillbase.ru

Fampridine Accord

Active substance: dalfampridine

Fampridine

Centralised EU authorisationActive

Marketing holder: Accord Healthcare S.L.U.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 11
  • AMPYRA
    TABLET, FILM COATED, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1
    0259-5010
    Merz Pharmaceuticals, LLC
  • AMPYRA
    TABLET, FILM COATED, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1
    10144-427
    Merz Pharmaceuticals, LLC
  • DALFAMPRIDINE
    TABLET, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1
    42571-275
    Micro Labs Limited
  • DALFAMPRIDINE
    TABLET, FILM COATED, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1
    65862-863
    Aurobindo Pharma Limited
  • DALFAMPRIDINE
    TABLET, EXTENDED RELEASE · DALFAMPRIDINE 10 mg/1
    72162-2459
    Bryant Ranch Prepack
All products in this country (11)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5b29-73fc-b37a-78816d0eeab9,01a1208d-839c-7171-b2e6-4ef27f89e816,01a12091-7027-76a6-80ed-444d810f1dc2,01a12092-5301-770b-82f6-7d640b7812ea,01a12093-a35c-74c6-92c8-265df8e82372;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005359
Registration status
Active
ATC code
N07XX07
Sources
  • product · EMA · EMEA/H/C/005359 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005359 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005359 · Verified 2026-10-09